Evidence map›Paper›PMID 36110664›Full record

ArticleJournal of pharmacy & bioallied sciences2022

An

Nagappan Nagappan, M Mohamed Ejaj, Thomson Mariadasan D'cruz, Gireesh Kumar Subbiah, Rameezuddin Tajuddin, Krithika Subbiah

Open access · goldAbstract read
In one paragraph

Article in Journal of pharmacy & bioallied sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Nagappan NagappanDepartment of Public Health Dentistry, Chettinad Dental College and Research Institute, Kelambakkam, Tamil Nadu, India.
M Mohamed EjajDepartment of Prosthodontics and Crown and Bridge, CSI College of Dental Science and Research Institute, Madurai, Tamil Nadu, India.
Thomson Mariadasan D'cruzDepartment of Oral and Maxillofacial Surgery, Dr. G D Pol Foundation's Y M T Dental College and Hospital, Navi Mumbai, Maharashtra, India.
Gireesh Kumar SubbiahDepartment of Health Sciences, University of Groningen, Groningen, Netherlands.
Rameezuddin TajuddinDepartment of Conservative Dentistry and Endodontics, Chettinad Dental College and Research Institute, Kelambakkam, Tamil Nadu, India.
Krithika SubbiahSchool of Public Health Sciences, University of Waterloo, Ontario, Canada.
Chettinad Health City · INDr D Y Patil Dental College & Hospital · INUniversity of Groningen · NLUniversity of Waterloo · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Oral diseases have a strong history of treating by natural remedies. Chemical plaque reduction techniques, including dental mouthwashes, are intriguing because they can help patients who are unable to maintain appropriate mechanical plaque management. They are a less technically difficult alternative to mechanical control. Aim: This study aimed to compare the antibacterial efficacy of an herbal and 0.2% chlorhexidine gluconate mouthrinse against Methodology: The antimicrobial effectiveness (zone of inhibition) of an herbal mouthrinse and chlorhexidine mouthrinse was determined by agar well diffusion method. Results: The zone of inhibition for control mouthrinse was 19 mm, and there was no zone of inhibition observed for the experimental mouthrinse. Conclusion: The result of this investigation suggests 0.2% chlorhexidine gluconate has a better antimicrobial activity than herbal mouthrinse.

Indexed as

Antimicrobial efficacychlorhexidineEnterococcus faecalisherbal

Identifiers

PMID36110664
PMCPMC9469464
OpenAlexW4285113423

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.